You don't need a doctor's office anymore.
Telehealth ships your glp 1 shots to your door after a video consult, so you never set foot in a pharmacy.
In 2026, the fastest legitimate route to a GLP-1 prescription, Wegovy, Zepbound, compounded semaglutide, compounded tirzepatide, runs entirely through your phone. The intake takes 15 minutes. A US-licensed clinician reviews your file the same day or the next morning. Medication ships from a US pharmacy and lands at your door inside a week. No waiting room, no copays, no insurance gymnastics.
This is what telehealth GLP-1 looks like now, what it actually costs, and how to sign up for the two providers our readers keep coming back to: MEDVi and Embody.
🔑 Key Takeaways
- Telehealth GLP-1 is legal, regulated, and now the cheapest legitimate way to start treatment without insurance.
- Two providers stand out for speed and price in 2026: MEDVi (broadest formulary, brand and compounded) and Embody (lowest flat price on compounded).
- Compounded semaglutide starts at $69/mo and compounded tirzepatide at $119/mo. Brand Wegovy and Zepbound run higher but are FDA-approved.
- You don't need labs, a referral, or a previous diagnosis to qualify. You do need a BMI of 27+ (or 30+ depending on the provider) and an honest medical history.
- Skip any platform that ships from outside the US, refuses to name its pharmacy, or pushes you toward grey-market vials.
The two telehealth GLP-1 providers worth using in 2026
Most platforms do the same five things. Price, formulary, and follow-up support are where they actually differ. These are the two services our readers consistently come back to.
If you're buying on price, Embody wins outright. If you want the option to start on compounded and switch to brand Wegovy or Zepbound later, MEDVi has the broader formulary. We've covered the broader market in our best online GLP-1 program ranking, and the cash-pay angle in GLP-1 without insurance.
How telehealth GLP-1 actually works
Five steps. Every legitimate provider follows the same outline.
1. Online intake
You fill out a 10 to 20 question medical history form. Height, weight, current medications, conditions, allergies, pregnancy status, and a few yes/no flags for things like personal or family history of medullary thyroid cancer (the only hard contraindication for GLP-1s). This takes about 15 minutes.
2. ID verification
Most platforms ask for a photo of your driver's license and a selfie. This is a regulatory requirement, not a sales tactic. It prevents prescription fraud and is the same check pharmacies run when filling controlled substances.
3. Clinician review
A US-licensed nurse practitioner, physician assistant, or physician reviews your intake. If everything checks out, they issue the prescription. If something's missing, they message you through the platform's portal. Turnaround: same day to 72 hours depending on the provider and the day of the week.
4. Pharmacy fulfillment
Brand prescriptions (Wegovy, Zepbound, Ozempic) go to a regular US pharmacy. Compounded prescriptions go to a 503A or 503B compounding pharmacy. Both ship cold-chain to your door with ice packs and tracking.
5. Follow-up and titration
You start at the lowest dose. Most providers schedule a check-in at week 4 to assess side effects and confirm you're ready to titrate up. Refills auto-ship on the schedule you select.
What telehealth GLP-1 does NOT include
No bloodwork. No A1C check. No liver panel. The intake is a medical history review, not a physical. If you have an underlying condition you're worried about, get baseline labs through your primary care doctor or a service like Quest before starting. The clinician can prescribe based on your self-reported history, but they can't catch a thyroid nodule on a video call.
How to sign up for MEDVi (step by step)
MEDVi is the broadest formulary in the telehealth GLP-1 space. They prescribe brand Wegovy and Zepbound for patients who want FDA-approved injectables, and compounded semaglutide and tirzepatide for patients who want the cash-pay route. Dietician visits and 24/7 message-based support are bundled in.
Here's exactly what the signup looks like.
- Start the intake. Open the MEDVi GLP-1 application. The first screen asks for your goal (weight loss, type 2 diabetes, or metabolic health) and your current weight and height.
- Answer the medical screening. You'll get a sequence of yes/no questions covering thyroid history, pancreatitis, gallbladder issues, kidney disease, and current medications. Answer honestly. False negatives here put you at real risk.
- Pick a treatment lane. MEDVi shows you which medications you qualify for based on your answers. If you have insurance and meet the BMI cutoff (30+, or 27+ with a comorbidity), brand Wegovy or Zepbound is offered first. If you're paying cash, compounded semaglutide or tirzepatide will be cheaper.
- Verify ID and pay. Upload a photo of your driver's license and a selfie. The first month is charged at signup. If you're approved, the charge stands. If you're not approved, you're refunded.
- Provider review. A clinician messages you within 24 to 72 hours. Most approvals come back faster than the high end of that window. If anything in your intake needs follow-up, they'll ask in the portal.
- First shipment ships. Once approved, your prescription is filled and shipped from a US pharmacy. Expect it in 3 to 5 business days, cold-packed with everything you need (vials or pens, syringes if compounded, alcohol swabs, instructions).
- Schedule your dietician call. MEDVi includes nutrition consults. Book the first one before your medication arrives so you have a plan day one.
What MEDVi costs in 2026
Compounded semaglutide pricing starts around $199/mo on the entry tier and scales with dose. Compounded tirzepatide is roughly $299 to $399/mo. Brand Wegovy and Zepbound through MEDVi run higher because the medication itself is the cost, not the platform fee. There's no separate membership charge. The dietician visits and 24/7 support are bundled.
How to sign up for Embody (step by step)
Embody is the price floor in this category. Compounded semaglutide is a flat $69/mo and compounded tirzepatide a flat $119/mo, against list prices of $299 and $349. There are no membership fees, no consultation fees, no add-ons and no long-term commitment. Every dose, provider visit and shipment is included in the monthly price.
The signup is shorter than MEDVi's because the formulary is narrower (compounded only). Here's the path:
- Take the eligibility quiz. Open the Embody intake. The first screen confirms your goal (weight loss) and runs you through 12 to 15 medical questions. Same content as MEDVi: BMI, current meds, thyroid history, pregnancy status.
- Choose your medication. If you qualify you'll see two injectable options, compounded semaglutide or compounded tirzepatide, plus a needle-free GLP-1 gum if you would rather skip injections. The injectable rates are flat monthly, so there is no plan-length tier to work out.
- Verify identity. Driver's license photo and selfie. Same regulatory step as everywhere else.
- Provider review. A licensed US clinician reviews your file before anything is dispensed.
- Pharmacy ships. A licensed US pharmacy fills the prescription and ships free in 1 to 2 days.
- Inject and titrate. Start at the lowest dose (typically 0.25 mg semaglutide or 2.5 mg tirzepatide weekly). Embody's care team is reachable around the clock for dose adjustments, and because every dose is included in the flat rate, titrating up does not change the bill.
The Embody pricing trade-off
The $69 and $119 rates are promotional against list prices of $299 and $349, so the number to check before you commit is what the plan renews at, not what it starts at. The upside is that doses are not priced separately: titrating up to a therapeutic dose does not move the monthly price the way dose-tiered programs do.
Brand vs compounded: which lane should you pick?
This is the question every new patient gets stuck on.
Brand Wegovy and Zepbound are FDA-approved, manufactured by Novo Nordisk and Eli Lilly, and run roughly $1,000 to $1,400/mo cash without insurance. With commercial insurance and prior authorization, they can drop to $25 to $200/mo. They're the gold-standard option, but the price wall is real if you don't have coverage.
Compounded semaglutide and tirzepatide are made by 503A or 503B compounding pharmacies under FDA oversight. They're not generic (GLP-1s have no generic). They're prepared from the same active pharmaceutical ingredients but priced for cash-pay patients, typically $69 to $400/mo depending on dose and provider. Compounded GLP-1s exist legally because the FDA recognizes them as medically necessary alternatives during shortages and for patient-specific needs.
If you have insurance that covers Wegovy or Zepbound, the brand route is almost always cheaper after copays. If you don't, compounded through MEDVi or Embody is the cheapest legitimate path that still goes through a licensed clinician and US pharmacy. We covered the cost math in detail in our GLP-1 prescription online guide.
Red flags: how to spot a sketchy telehealth GLP-1 site
- Ships from outside the US. Real telehealth providers use US pharmacies. If a site mentions international shipping, walk away.
- No clinician review. If the checkout completes without a medical intake and ID verification, you're buying grey-market vials, not a prescription.
- Won't name the pharmacy. Legitimate providers tell you which compounding pharmacy fills your prescription. Sketchy ones dodge the question.
- Pushes "research" or "not for human use" language. That's a peptide vendor, not a telehealth clinic. Different category, different risk profile, no clinician oversight.
- No COA or sourcing transparency. 503A and 503B pharmacies provide certificates of analysis on request. Anyone refusing is hiding something.
- Prices wildly below market. Compounded semaglutide under $100/mo is almost certainly imported powder reconstituted by an unlicensed operator.
Who shouldn't use telehealth GLP-1
Telehealth works for most adults who fit the BMI cutoff and don't have one of the hard contraindications. It doesn't work for everyone.
Skip telehealth and see an in-person doctor if you have:
- Personal or family history of medullary thyroid carcinoma or MEN2 syndrome (absolute contraindication for all GLP-1s)
- Active pancreatitis or a history of recurrent pancreatitis
- Severe gastroparesis
- Pregnancy or active attempts to conceive
- Type 1 diabetes (GLP-1s aren't approved for type 1; insulin management gets complicated)
- Active eating disorders (GLP-1s can mask warning signs)
If you're under 18, on dialysis, or have severe liver disease, your case needs in-person evaluation. Telehealth platforms will turn you down at intake, but going there first wastes a week.
What the first 90 days actually feel like
Weeks one through three on the starter dose are mostly an appetite shift. You'll notice you stop eating earlier in meals. Snacking thoughts get quieter. Some people get mild nausea in the first 48 hours after each injection, which fades. Constipation is common, water and fiber fix most of it.
Weeks four through eight is when the scale starts moving consistently. Most patients lose 4 to 8 lbs in the first month if they're titrating on schedule and eating in a moderate deficit. Don't compare yourself to social media before/afters; the people losing 30 lbs in a month are usually starting from a much higher BMI or aren't eating enough protein, which is its own problem.
Weeks nine through twelve is the dose ramp. By the end of month three, you're typically on the 0.5 mg or 1.0 mg semaglutide dose (or the equivalent tirzepatide step). This is where energy stabilizes and food noise drops sharply for most patients. If you've made it to week 12, the protocol is working.
Frequently Asked Questions
The bottom line
If you've been putting off GLP-1 treatment because you don't have insurance, don't have time for a clinic, or don't want to argue with your primary care doctor about it, telehealth solved that problem two years ago. The infrastructure is real, the pharmacies are licensed, and the price floor keeps dropping.
For the broadest formulary and bundled dietician support, start with MEDVi. For the lowest cash price on compounded semaglutide and tirzepatide, start with Embody. Both run the same five-step process. Both ship from US pharmacies. Both will refuse you if you don't qualify.
Pick the one that matches your budget and formulary preference, finish the intake tonight, and you'll have an answer before the weekend.
Medical Disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications including semaglutide and tirzepatide are prescription drugs that require evaluation by a licensed clinician. Telehealth platforms perform a medical history review, not a physical exam. Always disclose your full medical history during intake, follow your prescribing clinician's titration schedule, and seek in-person care for severe side effects including persistent abdominal pain, signs of pancreatitis, or allergic reactions. Compounded GLP-1 medications are dispensed under FDA 503A and 503B oversight but are not FDA-approved finished products.